← Back to headlines
BioCardia Prepares for CardiAMP FDA Submission
BioCardia has detailed its upcoming CardiAMP FDA submission, aiming for regulatory catalysts as trial data continues to indicate significant clinical benefits for the treatment.
25 Mar, 00:45 — 25 Mar, 00:45
Sources
Showing 1 of 1 sources
Related Stories
Philippine President Marcos Declares Energy Emergency, Rolls Out Subsidies, and Eyes Joint Gas Development Amid Oil Crisis
just now
President oversees rollout of fuel subsidies
just now
Gov’t allots P20B to buy 2 million barrels of diesel
just now
Philippine Government Reduces Airport and Ro-ro Terminal Fees
just now